These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [An experimental study of the antisecretory and antiulcer activities of kviditen].
    Author: Kaminka ME, Tupikina SM, Mashkovskiĭ MD.
    Journal: Eksp Klin Farmakol; 1994; 57(6):36-8. PubMed ID: 7756958.
    Abstract:
    Quiditene-(qunuclidyl-3)-di-(thyenel-2)carbinole hydrochloride was studied by using various experimental models. The agent was compared with H2-blockers. When gastrically used, quiditene in doses of 5-50 mg/kg dose-dependently decreased gastric acid secretion and prevented acute gastric mucosal lesions. As cimetidine and ranitidine, the agent accelerated chronic gastric ulcer healing. Quiditene has been allowed for clinical studies in Russia.
    [Abstract] [Full Text] [Related] [New Search]